AU2018354068C1 - Method for production of recombinant E. coli asparaginase - Google Patents

Method for production of recombinant E. coli asparaginase Download PDF

Info

Publication number
AU2018354068C1
AU2018354068C1 AU2018354068A AU2018354068A AU2018354068C1 AU 2018354068 C1 AU2018354068 C1 AU 2018354068C1 AU 2018354068 A AU2018354068 A AU 2018354068A AU 2018354068 A AU2018354068 A AU 2018354068A AU 2018354068 C1 AU2018354068 C1 AU 2018354068C1
Authority
AU
Australia
Prior art keywords
asparaginase
ala
val
leu
thr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2018354068A
Other languages
English (en)
Other versions
AU2018354068A1 (en
AU2018354068B9 (en
AU2018354068B2 (en
Inventor
Torben BRUCK
Russell J. Coleman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pelican Technology Holdings Inc
Original Assignee
Pelican Technology Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pelican Technology Holdings Inc filed Critical Pelican Technology Holdings Inc
Publication of AU2018354068A1 publication Critical patent/AU2018354068A1/en
Publication of AU2018354068B2 publication Critical patent/AU2018354068B2/en
Publication of AU2018354068B9 publication Critical patent/AU2018354068B9/en
Application granted granted Critical
Publication of AU2018354068C1 publication Critical patent/AU2018354068C1/en
Assigned to PELICAN TECHNOLOGY HOLDINGS, INC. reassignment PELICAN TECHNOLOGY HOLDINGS, INC. Request for Assignment Assignors: PFENEX INC.
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/78—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Pseudomonas
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
    • C12Y305/01—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amides (3.5.1)
    • C12Y305/01001—Asparaginase (3.5.1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • C12N9/82—Asparaginase (3.5.1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/38—Pseudomonas
    • C12R2001/39—Pseudomonas fluorescens
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2018354068A 2017-10-27 2018-10-17 Method for production of recombinant E. coli asparaginase Active AU2018354068C1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762578302P 2017-10-27 2017-10-27
US62/578,302 2017-10-27
PCT/US2018/056375 WO2019083794A1 (en) 2017-10-27 2018-10-17 PROCESS FOR PRODUCING EAR ASPARAGINASE. RECOMBINED COLI

Publications (4)

Publication Number Publication Date
AU2018354068A1 AU2018354068A1 (en) 2020-06-11
AU2018354068B2 AU2018354068B2 (en) 2022-11-10
AU2018354068B9 AU2018354068B9 (en) 2022-11-24
AU2018354068C1 true AU2018354068C1 (en) 2023-03-23

Family

ID=66243528

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2018354068A Active AU2018354068C1 (en) 2017-10-27 2018-10-17 Method for production of recombinant E. coli asparaginase

Country Status (7)

Country Link
US (2) US10662433B2 (https=)
EP (1) EP3701036A4 (https=)
JP (1) JP7358347B2 (https=)
CN (1) CN111278979B (https=)
AU (1) AU2018354068C1 (https=)
SG (1) SG11202003614WA (https=)
WO (1) WO2019083794A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019083794A1 (en) * 2017-10-27 2019-05-02 Pfenex Inc. PROCESS FOR PRODUCING EAR ASPARAGINASE. RECOMBINED COLI
JP7784804B2 (ja) * 2017-10-27 2025-12-12 フェネックス インク． 組み換えｅｒｗｉｎｉａアスパラギナーゼの製造のための方法
GB201912020D0 (en) * 2019-08-21 2019-10-02 Porton Biopharma Ltd Therapeutic Conjugate
JP2022553399A (ja) * 2019-10-25 2022-12-22 ジャズ ファーマシューティカルズ アイルランド リミテッド 組換えｌ－アスパラギナーゼ
CN110904085B (zh) * 2019-12-26 2021-04-16 常州千红生化制药股份有限公司 一种发酵法制备门冬酰胺酶的方法
CN118440925B (zh) * 2023-03-14 2024-12-24 医图生科(苏州)生命科学技术有限公司 一种低免疫原性门冬酰胺酶突变体及其制备方法和应用
WO2025157811A1 (fr) * 2024-01-23 2025-07-31 Asfalia Biologics Promoteurs inductibles par des molecules pharmacologiques

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0211639A2 (en) * 1985-08-06 1987-02-25 The Public Health Laboratory Service Board Production of L-asparaginase
US20080063632A1 (en) * 2006-06-30 2008-03-13 Filpula David R Recombinant host for producing l-asparaginase ii
US20110287443A1 (en) * 2010-03-30 2011-11-24 Pfenex Inc. High level expression of recombinant toxin proteins
US9453251B2 (en) * 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4551433A (en) 1981-05-18 1985-11-05 Genentech, Inc. Microbial hybrid promoters
US4755465A (en) 1983-04-25 1988-07-05 Genentech, Inc. Secretion of correctly processed human growth hormone in E. coli and Pseudomonas
US5281532A (en) 1983-07-27 1994-01-25 Mycogen Corporation Pseudomas hosts transformed with bacillus endotoxin genes
US4695462A (en) 1985-06-28 1987-09-22 Mycogen Corporation Cellular encapsulation of biological pesticides
US4695455A (en) 1985-01-22 1987-09-22 Mycogen Corporation Cellular encapsulation of pesticides produced by expression of heterologous genes
GB8517071D0 (en) 1985-07-05 1985-08-14 Hoffmann La Roche Gram-positive expression control sequence
US5128130A (en) 1988-01-22 1992-07-07 Mycogen Corporation Hybrid Bacillus thuringiensis gene, plasmid and transformed Pseudomonas fluorescens
US5055294A (en) 1988-03-03 1991-10-08 Mycogen Corporation Chimeric bacillus thuringiensis crystal protein gene comprising hd-73 and berliner 1715 toxin genes, transformed and expressed in pseudomonas fluorescens
US5169760A (en) 1989-07-27 1992-12-08 Mycogen Corporation Method, vectors, and host cells for the control of expression of heterologous genes from lac operated promoters
GB9017002D0 (en) 1990-08-02 1990-09-19 Health Lab Service Board Improved method for the purification of erwina l-asparaginase
CA2545610C (en) 2003-11-19 2014-03-25 Dow Global Technolgies Inc. Auxotrophic pseudomonas fluorescens bacteria for recombinant protein expression
AU2004317306B2 (en) 2003-11-21 2010-09-02 Pelican Technology Holdings, Inc. Improved expression systems with Sec-system secretion
US8603824B2 (en) * 2004-07-26 2013-12-10 Pfenex, Inc. Process for improved protein expression by strain engineering
EP2021489A2 (en) 2006-05-30 2009-02-11 Dow Global Technologies Inc. Codon optimization method
JP5714230B2 (ja) 2007-01-31 2015-05-07 フェネックス インコーポレイテッド 発現上昇のための細菌リーダー配列
WO2008128975A1 (en) 2007-04-20 2008-10-30 Dsm Ip Assets B.V. Novel asparaginases and uses thereof
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
JP5444553B2 (ja) * 2007-04-27 2014-03-19 フェネックス インコーポレイテッド 微生物宿主を迅速にスクリーニングして、異種タンパク質発現の収率および／または質が改善されている特定の株を同定する方法
WO2011003633A1 (en) 2009-07-06 2011-01-13 Alize Pharma Ii Pegylated l-asparaginase
CN103060299B (zh) * 2011-10-19 2017-05-03 北京安百胜生物科技有限公司 活性提高的l‑天冬酰胺酶变体
BR102014000585B1 (pt) 2014-01-10 2021-01-12 Coppe/Ufrj-Instituto Alberto Luiz Coimbra De Pós-Graduação l-asparaginase recombinante de zymomonas
KR102092225B1 (ko) 2014-04-30 2020-03-23 주식회사 엘지화학 고효율 분비능을 가지는 단백질 분비 인자 및 이를 포함하는 발현 벡터
JP6817939B2 (ja) 2014-12-01 2021-01-20 フェネックス インク． ペプチド産生のための融合パートナー
JP7784804B2 (ja) * 2017-10-27 2025-12-12 フェネックス インク． 組み換えｅｒｗｉｎｉａアスパラギナーゼの製造のための方法
WO2019083794A1 (en) * 2017-10-27 2019-05-02 Pfenex Inc. PROCESS FOR PRODUCING EAR ASPARAGINASE. RECOMBINED COLI

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0211639A2 (en) * 1985-08-06 1987-02-25 The Public Health Laboratory Service Board Production of L-asparaginase
US9453251B2 (en) * 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
US20080063632A1 (en) * 2006-06-30 2008-03-13 Filpula David R Recombinant host for producing l-asparaginase ii
JP2009542219A (ja) * 2006-06-30 2009-12-03 エンゾン ファーマスーティカルズ インコーポレイテッド Ｌ−アスパラギナーゼｉｉを産生する組換え宿主
US20110287443A1 (en) * 2010-03-30 2011-11-24 Pfenex Inc. High level expression of recombinant toxin proteins

Also Published As

Publication number Publication date
EP3701036A4 (en) 2021-09-01
CN111278979B (zh) 2024-05-31
US11046964B2 (en) 2021-06-29
AU2018354068A1 (en) 2020-06-11
SG11202003614WA (en) 2020-05-28
AU2018354068B9 (en) 2022-11-24
EP3701036A1 (en) 2020-09-02
AU2018354068B2 (en) 2022-11-10
JP7358347B2 (ja) 2023-10-10
JP2021500892A (ja) 2021-01-14
CN111278979A (zh) 2020-06-12
US10662433B2 (en) 2020-05-26
US20190127743A1 (en) 2019-05-02
WO2019083794A1 (en) 2019-05-02
US20200248193A1 (en) 2020-08-06

Similar Documents

Publication Publication Date Title
AU2018354067B2 (en) Method for production of recombinant Erwinia asparaginase
AU2018354068B9 (en) Method for production of recombinant E. coli asparaginase
EP2553102B1 (en) High level expression of recombinant toxin proteins
CA2794740C (en) Methods for g-csf production in a pseudomonas host cell
US20230100757A1 (en) Bacterial hosts for recombinant protein expression
EP3700915B1 (en) Bacterial leader sequences for periplasmic protein expression

Legal Events

Date Code Title Description
SREP Specification republished
DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 16 DEC 2022

DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT FILED 16 DEC 2022

FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: PELICAN TECHNOLOGY HOLDINGS, INC.

Free format text: FORMER OWNER(S): PFENEX INC.